Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9A Trial - TIMI 9A

Description:

The TIMI 9A trial compared the efficacy and safety of intravenous hirudin, a direct-acting thrombin inhibitor, with heparin as adjunctive therapy to thrombolysis and aspirin in patients with acute myocardial infarction.